Zisis Kozlakidis, Head, Laboratory Services at IARC/WHO reviewed patient-centric digital interaction in public health, highlighting the potential of integrated AI to accelerate discovery, enhance precision medicine and improve public health outcomes.
As AUTOMA+ 2025 Technology Partner, Boehringer Ingelheim Pharma GmbH & Co.KG, with Joachim Bär, Director DevOps CellCulture, as speaker, presented a workshop on digital plant modelling, discussing production, innovation and sustainability.
Beyond the main sessions, delegates had the chance to evaluate companies’ solutions in the exhibition zone. Sapio Sciences displayed their LIMS systems, Innowise highlighted AI & ML and I-care demonstrated software for asset performance and predictive maintenance.
Following a day of innovation and meetings, participants experienced relaxed networking, good cuisine and productive collaborations at the Gala Dinner in Casino Baumgarten.
Discussions on the second day revolved around AI-powered Pharma, covering smart supply chains, innovations in labels and packaging and digital pharma regulatory compliance. Riding the pharma logistics transformation wave, GSK’s Cédric Colon, Global Supply Chain Strategy Programme Management Global Process owner, presented why digitalisation and AI unlock supply chain value.
As the final accords of AUTOMA+ were reached and the last words said, the event’s magic was clear – it had united a constellation of professionals determined to shift the industry forward.
In 2026, AUTOMA+ continues its digital drive next in Zurich on 16-17 November: https://sh.bgs.group/3k6
Source: BGS Group